For instance, high levels of FL BARD1 correlate with a good prognosis in colon cancer patients, whereas BARD1 splicing isoforms are variably expressed both in normal and cancer cells [4], and the expression of epitopes, consistent with isoform but not FL BARD1 expression, was correlated with poor survival [5]. This evidence concerns the gene BARD1 and malignant colon neoplasm.